SC75741 appeared effective in suppressing CRC tumor cell growth by the NF-κB pathway (Supplementary Fig. S8a–d), and could restore the aberrant NF-κB signaling with deficient RNF138-NIBP axis (Supplementary Fig. S8e). Here, TRAPPC9 is linked to neoplasm.